Premium Only Content

First Type 1 Diabetes Patient Receiving Novel Gene-Edited Cell Replacement Therapy
Vertex Pharmaceuticals, a biotech based in Boston, is acquiring ViaCyte’s stem-cell derived cell replacement therapies to take the next step of providing a cure for Type 1 diabetes (T1D) to the public. In fact, they’re buying the whole company for 320 million dollars.
Back in February, ViaCyte and partner CRISPR Therapeutics dosed their first patient in a Phase I trial of VCTX210 for T1D. The therapy is an investigational, patient-derived, gene-edited, immune-evasive, stem cell therapy. The therapy combines CRISPR’s gene-editing expertise with ViaCyte’s proprietary pluripotent stem cell line. VCTX210 produces pancreatic cells that won’t be rejected by the patient’s immune system but should differentiate into pancreatic endoderm cells, which will then produce insulin.
-
LIVE
Rallied
1 hour agoWARZONE SOLO CHALLENGES ALL DAY
127 watching -
27:01
TheRoyaltyAutoService
7 hours agoAnother Shop Replaced The Timing Belt & Fuel Injectors On This Honda Pilot… Now It Has No Power!
391 -
LIVE
GritsGG
8 hours agoRanked Crim 2! Most Wins 3390+ 🧠
285 watching -
LIVE
IsaiahLCarter
22 hours agoJonah O. Wheeler: In Defense of Reality || APOSTATE RADIO #026
280 watching -
LIVE
Cewpins
3 hours agoSmoke Sesh🔥Gaming???💨420🍃!MJ !giveaway
47 watching -
LIVE
Phyxicx
1 hour agoShin Megami Tensei - Part 5 - 8/13/2025 | Chaos Route | Expert Difficulty
41 watching -
1:59:32
vivafrei
11 hours agoEp. 277: Russia Peace Talks! Trump D.C. Takeover Leads to Lawsuit! Heat Wave Lawsuit? AND MORE!
40.7K29 -
LIVE
Nerdrotic
3 hours ago $1.58 earnedTransient Lunar Phenomenon: Deeper into the Mysteries of the Moon | Forbidden Frontier #112
555 watching -
2:58:44
Barry Cunningham
1 day agoBREAKING NEWS: PRESIDENT TRUMP ABSOLUTELY TROLLS THE MEDIA! BIG WEEK AHEAD!
57.4K84 -
1:37:28
Sarah Westall
3 hours agoReal Intel: Power Struggles Fueled by Blackmail, Surveillance & Coercion w/ Dr. Dave Janda
33.9K15